EHA 2024: vídeos e entrevistas
19 vídeos do EHA 2024 publicados por EHA, OncLive, ecancer. Atualizado em 20/11/2026.
Hematopoietic Stem Cells in Health, Aging and Malignancy: Focus on Metabolism (EHA2024)EHA · 07/02/2025 · 7:38
Innovative Trial Design (EHA2024)EHA · 31/01/2025 · 17:32
Hereditary Hematological Malignancies (HHMs): A New Era of Discovery in MDS and AML (EHA2024)EHA · 24/01/2025 · 22:45
EHA2025 | welcome from Martin Dreyling, EHA2025 Scientific Program Committee ChairEHA · 22/01/2025 · 1:02
Hairy Cell Leukemia (HCL): Treatment of Relapsed Disease (EHA2024)EHA · 20/01/2025 · 17:41
First-line Treatment of Primary Central Nervous System Lymphoma (PCNSL) (EHA2024)EHA · 27/12/2024 · 18:22
Optimizing Global Care for Women with von Willebrand Disease (VWD) (EHA2024)EHA · 21/12/2024 · 22:24
Iron and Infections: Back to the Future (EHA2024)EHA · 13/12/2024 · 17:46
Long-term Outcomes in the Chemo-free era for Acute Promyelocytic Leukemia (EHA2024)EHA · 06/12/2024 · 19:10
EHA2024 | Scientific Program RecapEHA · 04/09/2024 · 1:48
EHA2024 Annual Congress ImpressionsEHA · 16/08/2024 · 1:10
Dr Lentzsch on Results for Linvoseltamab in Heavily Pretreated R/R MyelomaOncLive · 07/08/2024 · 1:23 · apoio da indústria
European Hematology Association (EHA) | Bridging breakthroughs in hematologyEHA · 01/08/2024 · 1:22
TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic leukaemiaecancer · 02/07/2024 · 4:35 · apoio da indústria
EHA 2024: Multiple myeloma roundupecancer · 26/06/2024 · 4:34 · apoio da indústria
More effective treatment options required for patients with MM post lenalidomide exposureecancer · 26/06/2024 · 2:40 · apoio da indústria
Combination of zanubrutinib and venetoclax shows promise in high-risk TN CLL/SLL with del(17p) a...ecancer · 26/06/2024 · 2:29 · apoio da indústria
Papers Unplugged: EHA and War in UkraineEHA · 19/06/2024 · 12:46
EHA2024 | From YERM attendees to organizersEHA · 15/05/2024 · 3:16